European Research Initiative on ALK-Related Malignancies (ERIA) United Kingdom (UK)

Research

Date range: 1 December 2020 - 30 November 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for European Research Initiative on ALK-Related Malignancies (ERIA) published between 1 December 2020 - 30 November 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for European Research Initiative on ALK-Related Malignancies (ERIA)
Count Share
1 0.14

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.14

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.00 0.00 0.10 0.00 0.02

Compare European Research Initiative on ALK-Related Malignancies (ERIA) with other institutions

Collaboration

Date range: 1 December 2020 - 30 November 2021

International vs. domestic collaboration by Share

  • 2.35% Domestic
  • 97.65% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with European Research Initiative on ALK-Related Malignancies (ERIA) by Share (1 total)

  1. European Research Initiative on ALK-Related Malignancies (ERIA) and University of Cambridge (0.16)
    European Research Initiative on ALK-Related Malignancies (ERIA)0.14
    University of Cambridge0.02

Top 10 international collaborators with European Research Initiative on ALK-Related Malignancies (ERIA) by Share (40 total)

  1. European Research Initiative on ALK-Related Malignancies (ERIA) and Medical University of Vienna (MUW) (0.24)
    European Research Initiative on ALK-Related Malignancies (ERIA)0.14
    Medical University of Vienna (MUW)0.10
  2. European Research Initiative on ALK-Related Malignancies (ERIA) and Helmholtz Association of German Research Centres (0.22)
    European Research Initiative on ALK-Related Malignancies (ERIA)0.14
    Helmholtz Association of German Research Centres0.08
  3. European Research Initiative on ALK-Related Malignancies (ERIA) and Harvard University (0.21)
    European Research Initiative on ALK-Related Malignancies (ERIA)0.14
    Harvard University0.07
  4. European Research Initiative on ALK-Related Malignancies (ERIA) and Central European Institute of Technology (CEITEC) (0.19)
    European Research Initiative on ALK-Related Malignancies (ERIA)0.14
    Central European Institute of Technology (CEITEC)0.05
  5. European Research Initiative on ALK-Related Malignancies (ERIA) and Karl Landsteiner University of Health Sciences (KL) (0.18)
    European Research Initiative on ALK-Related Malignancies (ERIA)0.14
    Karl Landsteiner University of Health Sciences (KL)0.05
  6. European Research Initiative on ALK-Related Malignancies (ERIA) and University of Hamburg (UHH) (0.18)
    European Research Initiative on ALK-Related Malignancies (ERIA)0.14
    University of Hamburg (UHH)0.05
  7. European Research Initiative on ALK-Related Malignancies (ERIA) and University of Washington (UW) (0.18)
    European Research Initiative on ALK-Related Malignancies (ERIA)0.14
    University of Washington (UW)0.04
  8. European Research Initiative on ALK-Related Malignancies (ERIA) and Experimental and Clinical Research Center (ECRC) (0.17)
    European Research Initiative on ALK-Related Malignancies (ERIA)0.14
    Experimental and Clinical Research Center (ECRC)0.04
  9. European Research Initiative on ALK-Related Malignancies (ERIA) and Charité - University Medicine Berlin (0.17)
    European Research Initiative on ALK-Related Malignancies (ERIA)0.14
    Charité - University Medicine Berlin0.03
  10. European Research Initiative on ALK-Related Malignancies (ERIA) and Assistance Publique-Hôpitaux de Paris (AP-HP) (0.17)
    European Research Initiative on ALK-Related Malignancies (ERIA)0.14
    Assistance Publique-Hôpitaux de Paris (AP-HP)0.03